Advertisement

Topics

Dozens of hospitals slashed use of two key heart drugs after price hikes

08:57 EDT 10 Aug 2017 | STAT

Early last year, a former Valeant Pharmaceuticals (VRX) executive told Congress that, when the company took huge price hikes on two life-saving heart drugs in 2013, the drug maker believed…

Original Article: Dozens of hospitals slashed use of two key heart drugs after price hikes

NEXT ARTICLE

More From BioPortfolio on "Dozens of hospitals slashed use of two key heart drugs after price hikes"

Quick Search
Advertisement
 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...